Late-Onset Proteinuria After Antithymocyte Globulin Induction and De Novo Sirolimus Monotherapy in Kidney Transplant Recipients

被引：2
|
作者：
Thomusch, Oliver [1 ]
Tittelbach-Helmrich, Dietlind [1 ]
Seifert, Gabriel [1 ]
Pisarski, Przemyslaw [1 ]
机构：
[1] Univ Freiburg, Dept Gen & Visceral Surg, D-79106 Freiburg, Germany
来源：
TRANSPLANTATION | 2011年 / 92卷 / 11期
关键词：
IMMUNOSUPPRESSION; CAMPATH-1H;
D O I：
10.1097/TP.0b013e3182366423
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E62 / E63
页数：2
相关论文
共 50 条
  • [41] Utility of Bimonthly Viral Monitoring for Late-Onset Cytomegalovirus Infections in Kidney Transplant Recipients
    Melgarejo, I.
    Jorgensen, D.
    Hariharan, S.
    Puttarajappa, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 780 - 780
  • [42] Impact of early red blood cell transfusion after kidney transplantation on de novo HLA sensitization in the setting of antithymocyte globulin induction
    Jouve, Thomas
    Rigault, Guillaume
    Janbon, Benedicte
    Tetaz, Rachel
    Terrier, Nicolas
    Masson, Dominique
    Rostaing, Lionel
    Malvezzi, Paolo
    TRANSPLANTATION, 2016, 100 (07) : S380 - S380
  • [43] A Systematic Approach to Minimizing Wound Problems for De Novo Sirolimus-Treated Kidney Transplant Recipients
    Tiong, Ho Yee
    Flechner, Stuart M.
    Zhou, Lingme
    Wee, Alvin
    Mastroianni, Barbara
    Savas, Kathy
    Goldfarb, David
    Derweesh, Ithaar
    Modlin, Charles
    TRANSPLANTATION, 2009, 87 (02) : 296 - 302
  • [44] Preemptive Therapy Versus Valgancyclovir Prophylaxis in Cytomegalovirus-positive Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction
    Couzi, L.
    Helou, S.
    Bachelet, T.
    Martin, S.
    Moreau, K.
    Morel, D.
    Lafon, M. E.
    Garrigue, I.
    Merville, P.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2809 - 2813
  • [45] Alemtuzumab vs Antithymocyte Globulin Induction in Hepatitis C Viremic Donors to Hepatis C Negative Kidney Transplant Recipients
    Walter, K.
    Mincemoyer, L.
    Giang, J.
    Suero, J.
    Shah, N.
    Szempruch, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 689 - 690
  • [46] Preemptive Therapy Versus Valganciclovir Prophylaxis in CMV R plus Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction
    Couzi, L.
    Helou, S.
    Bachelet, T.
    Martin, S.
    Moreau, K.
    Morel, D.
    Lafon, M. -E.
    Garrigue, I.
    Merville, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 469 - 469
  • [47] Antithymocyte Globulin Is Associated With a Lower Incidence of De Novo Donor-Specific Antibodies in Moderately Sensitized Renal Transplant Recipients
    Brokhof, Marissa M.
    Sollinger, Hans W.
    Hager, David R.
    Muth, Brenda L.
    Pirsch, John D.
    Fernandez, Luis A.
    Bellingham, Janet M.
    Mezrich, Joshua D.
    Foley, David P.
    D'Alessandro, Anthony M.
    Odorico, Jon S.
    Mohamed, Maha A.
    Vidyasagar, Vijay
    Ellis, Thomas M.
    Kaufman, Dixon B.
    Djamali, Arjang
    TRANSPLANTATION, 2014, 97 (06) : 612 - 617
  • [48] No evidence of indirect effects of late-onset cytomegalovirus (CMV) disease after valganciclovir (VGC) prophylaxis in kidney transplant recipients
    Manuel, Oriol
    Lamoth, Frederic
    Meylan, Pascal R.
    Fellay, Jacques
    Venetz, Jean-Pierre
    Pascual, Manuel
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 527 - 527
  • [49] Impact of Early Red Blood Cell Transfusion After Kidney Transplantation on De Novo HLA Sensitization in the Setting of Antithymocyte Globulin Induction.
    Jouve, T.
    Rigault, G.
    Janbon, B.
    Tetaz, R.
    Terrier, N.
    Masson, D.
    Rostaing, L.
    Malvezzi, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 610 - 610
  • [50] Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation
    Veroux, Massimiliano
    Tallarita, Tiziano
    Corona, Daniela
    Sinagra, Nunziata
    Giaquinta, Alessia
    Zerbo, Domenico
    Guerrieri, Carmela
    D'Assoro, Antonino
    Cimino, Sebastiano
    Veroux, Pierfrancesco
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,
12345